Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Citius Pharmaceuticals, Inc.Citius Pharmaceuticals Reports Q3 2025 Financial Results with $9.2 Million Net Loss
Affinity Bancshares, Inc.Affinity Bancshares Reports Increased Net Income and Asset Growth in Q2 2025
Stran & Company, Inc.Stran & Company Reports 95.2% Revenue Growth to $32.6 Million in Q2 2025
Spero Therapeutics, Inc.Spero Therapeutics Reports 38.9% Revenue Growth and Improved Net Loss in Q2 2025
GD Culture Group LtdGD Culture Group Reports Significant Asset Growth and Reduced Net Losses in Q2 2025
Central Plains Bancshares, Inc.Central Plains Bancshares Reports Increased Net Income and Earnings Per Share for Q2 2025
BioRestorative Therapies, Inc.BioRestorative Therapies Reports Revenue Growth but Significant Net Loss in Latest 10-Q Filing
Microbot Medical Inc.Microbot Medical Reports Increased Net Loss and Significant Asset Growth in Latest 10-Q Filing
Moleculin Biotech, Inc.Moleculin Biotech Reports $7.6 Million Net Loss in Q2 2025, Seeks Additional Funding
CITIUS ONCOLOGY, INC.Citius Oncology Reports Increased Net Loss and Prepares for LYMPHIR Launch
PRECIGEN, INC.Precigen Reports 19.4% Revenue Growth in Q2 2025, Despite $26.6M Net Loss
Kodiak AI, Inc.Ares Acquisition Corporation II Reports Significant Decline in Net Income for Q2 2025
IRIDEX CORPIRIDEX Reports 7.4% Revenue Growth in Q2 2025, Net Loss Improves
Erasca, Inc.Erasca Reports $33.9 Million Net Loss in Q2 2025, Down from $63.2 Million Last Year
GCT Semiconductor Holding, Inc.GCT Semiconductor Reports 19% Revenue Decline in Q2 2025, Faces Financial Challenges
FLANIGANS ENTERPRISES INCFlanigan's Enterprises Reports 6.24% Revenue Growth to $52.2 Million
GoHealth, Inc.GoHealth Reports Q2 2025 Revenue Decline and Significant Net Loss
Fathom Holdings Inc.Fathom Holdings Reports 36% Revenue Growth to $121.4 Million in Latest Quarter
Virginia National Bankshares CorpVirginia National Bankshares Reports Q2 2025 Financial Results with $4.2 Million Net Income
Lyra Therapeutics, Inc.Lyra Therapeutics Reports Decrease in Collaboration Revenue and Improved Net Loss in Latest 10-Q Filing
GBank Financial Holdings Inc.GBank Financial Holdings Reports $4.8 Million Net Income for Q2 2025
MEXCO ENERGY CORPMexco Energy Corporation Reports Q2 2025 Financial Results with Increased Revenues and Decreased Net Income
SPRUCE POWER HOLDING CORPSpruce Power Reports 48% Revenue Growth to $33.2 Million in Q2 2025
Verrica Pharmaceuticals Inc.Verrica Pharmaceuticals Reports $12.7M Revenue and $204K Net Income in Q2 2025
Oric Pharmaceuticals, Inc.ORIC Pharmaceuticals Reports $36.4 Million Net Loss in Q2 2025, Increases Focus on Key Clinical Programs